Alnylam Pharmaceuticals
ALNY
#635
Rank
ยฃ25.61 B
Marketcap
ยฃ198.59
Share price
-0.68%
Change (1 day)
45.88%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: ยฃ25.61 Billion

As of December 2024 Alnylam Pharmaceuticals has a market cap of ยฃ25.61 Billion. This makes Alnylam Pharmaceuticals the world's 635th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2024

End of year Market Cap

Year Marketcap Change
2024ยฃ25.61 B35.85%
2023ยฃ18.85 B-21.98%
2022ยฃ24.16 B60.84%
2021ยฃ15.02 B35.63%
2020ยฃ11.07 B12.43%
2019ยฃ9.85 B69.55%
2018ยฃ5.81 B-37.66%
2017ยฃ9.32 B258.04%
2016ยฃ2.60 B-51.83%
2015ยฃ5.40 B12.38%
2014ยฃ4.80 B93.58%
2013ยฃ2.48 B319.24%
2012ยฃ0.59 B164.54%
2011ยฃ0.22 B-17.16%
2010ยฃ0.27 B-40.63%
2009ยฃ0.45 B-34.81%
2008ยฃ0.69 B17.08%
2007ยฃ0.59 B47.44%
2006ยฃ0.40 B170.95%
2005ยฃ0.14 B99.11%
2004ยฃ75.03 M

End of Day market cap according to different sources

On Dec 2nd, 2024 the market cap of Alnylam Pharmaceuticals was reported to be:

ยฃ25.85 Billion
by Yahoo Finance info icon info icon
ยฃ25.85 Billion
by CompaniesMarketCap info icon info icon
ยฃ25.79 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ยฃ2.64 B-89.68%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ65.39 B 155.31%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ9.54 B-62.75%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.81 B-96.83%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ83.86 M-99.67%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ166.83 B 551.31%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
ยฃ96.47 B 276.65%๐Ÿ‡ซ๐Ÿ‡ท France
ยฃ15.70 B-38.70%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel